Business
Avicanna (TSX: AVCN) Completes First Commercial Exports of CBD to South Africa and the United Kingdom
Avicanna (TSX: AVCN) Completes First Commercial Exports of CBD to South Africa and the Uni...
About this update from Avicanna Inc
[{"type":"text","content":"\n\n\n\nAvicanna (TSX: AVCN) Completes First Commercial Exports of CBD to South Africa and the United Kingdom\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, Oct. 24, 2019\n\n\n\n/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/\n TORONTO, Oct. 24, 2019 /CNW/ - Avicanna Inc. (\"Avicanna\" or the \"Company\") (TSX: AVCN)(OTCQX: AVCNF), a biopharmaceutical company focused on the development, manufacturing and commercialization of cannabinoid-based products, is pleased to announce that Santa Marta Golden Hemp S.A.S. (\"SMGH\"), its majority owned subsidiary, has completed commercial exports of its Aureus™ brand of CBD-based products to South Africa and the United Kingdom (collectively, the \"Jurisdictions\"). \n\n \n \n\n \nThe Aureus brand of products include an organic and sustainable line of plant-derived active pharmaceutical ingredients (\"APIs\") and bulk CBD formulations developed by Avicanna in collaboration with SMGH and Sativa Nativa S.A.S. (\"Sativa Nativa\"), which is also a majority owned subsidiary of Avicanna. These initial sales included the export of CBD isolate and 4% bulk formulation for CBD oil sublingual sprays. Each of the above exports has been completed in accordance with all applicable laws in the Jurisdictions.\nAras Azadian, Avicanna's Chief Executive Officer, stated \"We are excited to bring the Aureus brand of cannabinoid APIs to our international customers. We believe these initial sales further validate the brand's opportunities in these two countries, as well as the potential for us to actively market our APIs across the globe to manufacturers of CBD products. We believe the Aureus brand of API products will become a leader in organic and sustainable cannabinoid raw materials and the gold standard with respect to global quality controls, which we believe are necessary for the evolution of a worldwide cannabinoid industry.\"\nAbout Aureus\nThe Aur...